GPT and metabolic dysfunction-associated steatotic liver disease: Regarding laboratory indices, there were no significant differences in FBS, grade of NAFLD in ultrasound, ALT and AST, lipid profiles, and urine-specific gravity levels between two groups at the beginning of study (Tables 1 and 2).